Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 302.60
Change Today -18.20 / -5.67%
Volume 242.8K
ALMD On Other Exchanges
Symbol
Exchange
Tel Aviv
As of 10:24 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

allium medical solutions ltd (ALMD) Snapshot

Open
$320.80
Previous Close
$320.80
Day High
$324.10
Day Low
$300.00
52 Week High
07/5/15 - $324.70
52 Week Low
03/18/15 - $94.59
Market Cap
80.4M
Average Volume 10 Days
138.1K
EPS TTM
$-7.13
Shares Outstanding
26.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ALLIUM MEDICAL SOLUTIONS LTD (ALMD)

Related News

No related news articles were found.

allium medical solutions ltd (ALMD) Related Businessweek News

No Related Businessweek News Found

allium medical solutions ltd (ALMD) Details

Allium Medical Solutions Ltd., a medical device company, engages in the development, manufacture, and marketing of minimally invasive products in Israel and internationally. The company offers covered stents, such as ureteral, round posterior, triangular prostatic, bulbar, and biliary stents. It also provides uro-gynecology products, including EndoFast Reliant Systems for reinforcement of the vaginal wall; EndoFast Resorb kits for fixation of surgical mesh to tissues for tissue reinforcement; EndoFast Reliant MN, an implantable, sub-urethral support sling for the treatment of male stress urinary incontinence; and EndoFast Reliant SCP for fixation of surgical mesh to tissue for tissue reinforcement during laparotomy or laparoscopic Sacrocolpopexy approach. In addition, the company offers gastro-duodenal sleeves for the treatment of type 2 diabetes mellitus and obesity; and WIRION EPD system, a distal embolic protection system. Allium Medical Solutions Ltd. is headquartered in Caesarea, Israel.

allium medical solutions ltd (ALMD) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: 1.3M
Chief Operational Officer
Total Annual Compensation: 618.0K
Vice President of Engineering & Technology
Total Annual Compensation: 665.0K
Vice President of Business Development & Mark...
Total Annual Compensation: 545.0K
Compensation as of Fiscal Year 2014.

allium medical solutions ltd (ALMD) Key Developments

Allium Medical Receives FDA Clearance to Market Gardia's WIRION System in the US for the Carotid Indication

Allium Medical announced that it received FDA clearance to market Gardia's WIRION system in the US for the carotid indication. The FDA clearance was received in accordance with the timetable the company announced. The approval follows the unprecedented success of the company, which included meeting all clinical endpoints already at the early stage of recruiting half the patients (120 patients out of a full cohort of 240).

Allium Medical's Gardia Successfully Met All Clinical Study Endpoints Set by the FDA

Allium Medical announced that the FDA confirmed Gardia successfully achieved all the clinical study objectives at the early stage of recruitment of half the number of patients (120 patients out of 240), based on the interim results. According to the study protocol, in order to meet the primary end-point of the study, which is the safety profile, already at this early stage, the Company was required to meet very stringent statistical criteria in relation to the statistical criteria required for the full study. In view of the successful compliance with all clinical trial objectives at this early stage, the Company decided to stop recruiting additional patients. The Gardia WIRION system, which has been used successfully in over 250 procedures, in a variety of clinical indications, received a very favorable feedback from leading European physicians performing these procedures. The system includes significant competitive advantages over other FDA cleared products of other companies. The WIRION system is a unique, patent-protected embolic protection filter system that provides protection from blood clots and emboli produced during catheterization procedures for the opening of blocked blood vessels. The system has a unique locking mechanism that allows the physician to use any guide wire of choice and place the filter at a desired location. The flexibility to place the filter anywhere over any guide wire of choice makes the procedure more safe, convenient and simple for use, thus presenting significant advantages with respect to other protection solutions available in the market.

Allium Medical Solutions Ltd. Auditor Raises 'Going Concern' Doubt

Allium Medical Solutions Ltd. filed its Annual on Mar 12, 2015 for the period ending Dec 31, 2014. In this report its auditor, Kesselman & Kesselman, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALMD:IT 302.60 -18.20

ALMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALMD.
View Industry Companies
 

Industry Analysis

ALMD

Industry Average

Valuation ALMD Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLIUM MEDICAL SOLUTIONS LTD, please visit www.allium-medical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.